Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 117 results.
User Information
Export Records
  1. 1.   Allosteric modulation of NF1 GAP: Differential distributions of catalytically competent populations in loss-of-function and gain-of-function mutants
  2. Xu,Liang; Jang,Hyunbum; Nussinov,Ruth
  3. Protein Science : a publication of the Protein Society. 2025, Feb; 34(2): e70042.
  1. 2.   The small molecule inhibitor NAV-2729 has a complex target profile including multiple ADP-ribosylation factor regulatory proteins
  2. Rosenberg, Eric M; Jian, Xiaoying; Soubias,Olivier; Yoon, Hye-Young; Yadav, Mukesh P; Hammoudeh, Sarah; Pallikkuth, Sandeep; Akpan, Itoro; Chen, Pei-Wen; Maity, Tapan K; Jenkins, Lisa M; Yohe,Marielle; Byrd,Robert; Randazzo, Paul A
  3. The Journal of Biological Chemistry. 2023, Feb 07; 299(3): 102992.
  1. 3.   Drugging multiple same-allele driver mutations in cancer
  2. Nussinov,Ruth; Zhang,Mingzhen; Maloney,Ryan; Jang, Hyunbum
  3. Expert Opinion on Drug Discovery. 2021, Aug; 16(8): 823-828.
  1. 4.   Structural Insights into the SPRED1-Neurofibromin-KRAS Complex and Disruption of SPRED1-Neurofibromin Interaction by Oncogenic EGFR
  2. Yan,Wupeng; Markegard, Evan; Dharmaiah, Srisathiyanarayanan; Urisman, Anatoly; Drew, Matthew; Esposito,Dom; Scheffzek, Klaus; Nissley,Dwight; McCormick, Frank; Simanshu,Dhirendra
  3. Cell reports. 2020, Jul 21; 32(3): 107909.
  1. 5.   Optimization of sortase A ligation for flexible engineering of complex protein systems
  2. Li,Jess; Zhang,Yue; Soubias,Olivier; Khago,Domarin; Chao, Fa-an; Li, Yifei; Shaw, Katherine; Byrd,Robert
  3. JOURNAL OF BIOLOGICAL CHEMISTRY. 2020, FEB 28; 295(9): 2664-2675.
  1. 6.   Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer
  2. Sherekar,Mukul; Han, Sae-Won; Ghirlando, Rodolfo; Messing,Simon; Drew,Matt; Rabara,Dana; Waybright,Tim; Juneja, Puneet; O'Neill, Hugh; Stanley, Christopher B; Bhowmik, Debsindhu; Ramanathan, Arvind; Subramaniam,Sriram; Nissley,Dwight; Gillette,Bill; McCormick, Frank; Esposito,Dom
  3. The Journal of biological chemistry. 2020, JAN 24; 295(4): 1105-1119.
  1. 7.   NRARP displays either pro- or anti-tumoral roles in T-cell acute lymphoblastic leukemia depending on Notch and Wnt signaling
  2. Pinto, Inês; Duque, Mafalda; Gonçalves, Joana; Akkapeddi, Padma; Oliveira, Mariana L; Cabrita, Rita; Yunes, J Andrés; Durum,Scott; Barata, João T; Fragoso, Rita
  3. ONCOGENE. 2020, JAN; 39(5): 975-986.
  1. 8.   Development of Lentiviral Vectors for HIV-1 Gene Therapy with Vif-Resistant APOBEC3G
  2. Frankenberry,Krista; Ackerman, Daniel; Timberlake, Nina D; Hamscher, Maria; Nikolaitchik,Olga; Hu,Wei-Shau; Torbett, Bruce E; Pathak,Vinay
  3. Molecular therapy. Nucleic acids. 2019, Dec 6; 18: 1023-1038.
  1. 9.   Functional Expression and Characterization of Human Myristoylated-Arf1 in Nanodisc Membrane Mimetics
  2. Li, Yifei; Soubias,Olivier; Li,Jess; Sun, Shangjin; Randazzo, Paul A.; Byrd,Robert
  3. BIOCHEMISTRY. 2019, MAR 12; 58(10): 1423-1431.
  1. 10.   Pillars Article: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA 1987. 84: 9233-9237.
  2. Yoshimura, Teizo; Matsushima, Kouji; Tanaka, Shuji; Robinson, Elizabeth A.; Appella, Ettore; Oppenheim, Joost; Leonard, Edward J.
  3. JOURNAL OF IMMUNOLOGY. 2019, Jan 1; 202(1): 5-9.
  1. 11.   The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells
  2. Alexandre, K. B.; Gray, E. S.; Mufhandu, H.; McMahon, J. B.; Chakauya, E.; O'Keefe, B. R.; Chikwamba, R.; Morris, L.
  3. Virology. 2012, Feb; 423(2): 175-186.
  1. 12.   Investigation of Griffithsin's Interactions with Human Cells Confirms Its Outstanding Safety and Efficacy Profile as a Microbicide Candidate
  2. Kouokam, J. C.; Huskens, D.; Schols, D.; Johannemann, A.; Riedell, S. K.; Walter, W.; Walker, J. M.; Matoba, N.; O'Keefe, B. R.; Palmer, K. E.
  3. Plos One. 2011, Aug; 6(8):
  1. 13.   Anti-HIV microbicide development: targeting the virus is the key
  2. O'Keefe, B. R.
  3. Future Virology. 2011, May; 6(5): 553-556.
  1. 14.   Monomerization of Viral Entry Inhibitor Griffithsin Elucidates the Relationship between Multivalent Binding to Carbohydrates and anti-HIV Activity
  2. Moulaei, T.; Shenoy, S. R.; Giomarelli, B.; Thomas, C.; McMahon, J. B.; Dauter, Z.; O'Keefe, B. R.; Wlodawer, A.
  3. Structure. 2010, Sep; 18(9): 1104-1115.
  1. 15.   Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and Cancer
  2. Cao, L. A.; Yu, Y. K.; Bilke, S.; Walker, R. L.; Mayeenuddin, L. H.; Azorsa, D. O.; Yang, F.; Pineda, M.; Helman, L. J.; Meltzer, P. S.
  3. Cancer Research. 2010, Aug; 70(16): 6497-6508.
  1. 17.   Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin
  2. Alexandre, K. B.; Gray, E. S.; Lambson, B. E.; Moore, P. L.; Choge, I. A.; Mlisana, K.; Karim, S. S. A.; McMahon, J.; O'Keefe, B.; Chikwamba, R.; Morris, L.
  3. Virology. 2010, Jun; 402(1): 187-196.
  1. 18.   Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae
  2. O'Keefe, B. R.; Giomarelli, B.; Barnard, D. L.; Shenoy, S. R.; Chan, P. K. S.; McMahon, J. B.; Palmer, K. E.; Barnett, B. W.; Meyerholz, D. K.; Wohlford-Lenane, C. L.; McCray, P. B.
  3. Journal of Virology. 2010, Mar; 84(5): 2511-2521.
  1. 19.   Multivalent Interactions with gp120 Are Required for the Anti-HIV Activity of Cyanovirin
  2. Liu, Y. A.; Carroll, J. R.; Holt, L. A.; McMahon, J.; Giomarelli, B.; Ghirl, a
  3. Biopolymers. 2009 92(3): 194-200.
  1. 20.   Defective Plasmacytoid Dendritic Cell-NK Cell Cross-Talk in HIV Infection
  2. Reitano, K. N.; Kottilil, S.; Gille, C. M.; Zhang, X.; Yan, M.; O'Shea, M. A.; Roby, G.; Hallahan, C. W.; Yang, J.; Lempicki, R. A.; Arthos, J.; Fauci, A. S.
  3. Aids Research and Human Retroviruses. 2009 25(10): 1029-1037.
  1. 21.   Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms
  2. Satyanarayana, A.; Kaldis, P.
  3. Oncogene. 2009 28(33): 2925-2939.
  1. 22.   Correlation between recombinase activating gene 1 ubiquitin ligase activity and V(D)J recombination
  2. Simkus, C.; Bhattacharyya, A.; Zhou, M.; Veenstra, T. D.; Jones, J. M.
  3. Immunology. 2009 128(2): 206-217.
  1. 23.   Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models
  2. Taylor, J. G.; Cheuk, A. T.; Tsang, P. S.; Chung, J. Y.; Song, Y. K.; Desai, K.; Yu, Y. L.; Chen, Q. R.; Shah, K.; Youngblood, V.; Fang, J.; Kim, S. Y.; Yeung, C.; Helman, L. J.; Mendoza, A.; Ngo, V.; Staudt, L. M.; Wei, J. S.; Khanna, C.
  3. Journal of Clinical Investigation. 2009 119(11): 3395-3407.
  1. 24.   Functional characterization of filamin A interacting protein 1-like, a novel candidate for antivascular cancer therapy
  2. Kwon, M.; Hanna, E.; Lorang, D.; He, M.; Quick, J. S.; Adem, A.; Stevenson, C.; Chung, J. Y.; Hewitt, S. M.; Zudaire, E.; Esposito, D.; Cuttitta, F.; Libutti, S. K.
  3. Cancer Research. 2008 68(18): 7332-7341.
  1. 25.   Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N
  2. Smee, D. F.; Bailey, K. W.; Wong, M. H.; O'Keefe, B. R.; Gustafson, K. R.; Mishin, V. P.; Gubareva, L. V.
  3. Antiviral Research. 2008 80(3): 266-271.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel